Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP904162.RAIuEE0LLpVd9_v1ikwCtpuX_fpoqEWgzzF2TkOjIAqBY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP904162.RAIuEE0LLpVd9_v1ikwCtpuX_fpoqEWgzzF2TkOjIAqBY130_assertion type Assertion NP904162.RAIuEE0LLpVd9_v1ikwCtpuX_fpoqEWgzzF2TkOjIAqBY130_head.
- NP904162.RAIuEE0LLpVd9_v1ikwCtpuX_fpoqEWgzzF2TkOjIAqBY130_assertion wasGeneratedBy ECO_0000203 NP904162.RAIuEE0LLpVd9_v1ikwCtpuX_fpoqEWgzzF2TkOjIAqBY130_provenance.
- NP904162.RAIuEE0LLpVd9_v1ikwCtpuX_fpoqEWgzzF2TkOjIAqBY130_assertion wasDerivedFrom befree-2016 NP904162.RAIuEE0LLpVd9_v1ikwCtpuX_fpoqEWgzzF2TkOjIAqBY130_provenance.
- NP904162.RAIuEE0LLpVd9_v1ikwCtpuX_fpoqEWgzzF2TkOjIAqBY130_assertion SIO_000772 21696295 NP904162.RAIuEE0LLpVd9_v1ikwCtpuX_fpoqEWgzzF2TkOjIAqBY130_provenance.
- NP904162.RAIuEE0LLpVd9_v1ikwCtpuX_fpoqEWgzzF2TkOjIAqBY130_assertion evidence source_evidence_literature NP904162.RAIuEE0LLpVd9_v1ikwCtpuX_fpoqEWgzzF2TkOjIAqBY130_provenance.
- NP904162.RAIuEE0LLpVd9_v1ikwCtpuX_fpoqEWgzzF2TkOjIAqBY130_assertion description "[Overexpression or HER-2 gene amplification occurs in approximately 25% of invasive breast cancers and predicts response to the targeting therapeutic antibody trastuzumab (1).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP904162.RAIuEE0LLpVd9_v1ikwCtpuX_fpoqEWgzzF2TkOjIAqBY130_provenance.